[Intra-arterial cisplatin and concurrent radiation for invasive bladder cancer]. 1991

N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
Department of Urology, University of Tsukuba.

Fifteen patients with invasive bladder cancer were treated with selective intra-arterial cisplatin and external beam radiotherapy (30.6 Gy over 3 weeks) prior to a planned cystectomy. Cisplatin, in total 200 mg, was administered via bilateral internal iliac artery infusion during the course of radiotherapy. Seven patients were evaluated for local response. Partial response (PR) was revealed in 4, and minor response (MR) in 3. Ten patients received total cystectomy, and pathological effects by the criteria adipted by Japanese Urological Association and The Japanese Society of Pathology, were as follows: Ef. 3 in 1 case, Ef. 2 in 6. Ef. 1b in 1 and Ef. 1a in 2. Down staging was observed in 8 patients from the clinical to the pathological stage. Thirteen patients are alive for 21 months. Two patients have died (1 lung infarction, 1 pancreatic cancer). Though nausea and sciatica-like pain were observed in some cases, there was no severe systemic side effects such as bone marrow suppression and renal toxicity. From these results it is concluded that this therapeutic modality could be effective in the preoperative work-up of candidates for total cystectomy, and also that it could be useful in the treatment of patients in whom total cystectomy is contraindicated.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females

Related Publications

N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
January 2015, Indian journal of urology : IJU : journal of the Urological Society of India,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
August 1987, The Journal of urology,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
January 1996, International journal of urology : official journal of the Japanese Urological Association,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
January 1998, Anticancer research,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
July 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
February 1999, Hinyokika kiyo. Acta urologica Japonica,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
December 2003, Journal of experimental & clinical cancer research : CR,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
October 1999, Gan to kagaku ryoho. Cancer & chemotherapy,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
February 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
N Miyanaga, and M Ohtani, and R Noguchi, and K Uchida, and H Akaza, and K Koiso, and H Tatsuzaki, and K Ohara, and H Tsuji, and T Inada
February 2008, American journal of clinical oncology,
Copied contents to your clipboard!